Explore News By Topic

04/15/2016

2016 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients

The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the AACR Annual Meeting. The Prostate Cancer Foundation is one of 13 organizations sponsoring this highly competitive awards program in conjunction with the AACR. The 2016 AACR Annual Meeting... Read More

03/31/2016

INHIBITING PROTEIN COULD OFFER NEW HOPE FOR LETHAL PROSTATE CANCER, NEW PCF STUDY SHOWS

March 31, 2016 - A protein called N-Myc that is overexpressed in neuroendocrine prostate cancer (NEPC) may actually drive its progression, and its disruption causes a reduction in tumor growth, reports a new study by Lori Milken - PCF Young Investigator John Kyung Lee, MD of the University of California,... Read More

01/08/2016

Lands’ End launches Blue Oxford campaign to help raise funds for the Prostate Cancer Foundation

LANDS’ END LAUNCHES BLUE OXFORD CAMPAIGN TO HELP RAISE FUNDS FOR THE PROSTATE CANCER FOUNDATION Lands’ End Declares January 13 Blue Oxford Day DODGEVILLE, WIS. January 8, 2016 -- Lands’ End is launching the Blue Oxford campaign, an initiative created to help raise awareness and support for the Prostate Cancer... Read More

01/05/2016

Family History Of Prostate Cancer Tied To Heightened Risk Of Disease

TUESDAY, Jan. 5, 2016 -- A new study by PCF researcher Lorelei Mucci, ScD, reports new evidence for the "significant heritability" of prostate cancer. Her exciting results, published in the January 5 issue of The Journal of the American Medical Association, provide a new, compelling reason for men to get... Read More

10/28/2015

Landmark Trial Shows Same Drug Effective In Ovarian, Prostate Cancer

Oct. 28, 2015 -- A major new trial, funded in part by the Prostate Cancer Foundation (PCF), has concluded that a pioneering drug—Olaparib—developed to treat women with inherited cancers can also benefit men with certain types of advanced prostate cancer. These exciting results were published today by the study's leaders... Read More

10/22/2015

PROSTATE CANCER FOUNDATION AWARDS OVER $3.8 MILLION TO EARLY CAREER SCIENTISTS

SANTA MONICA, CA Oct. 22, 2015 – The Prostate Cancer Foundation (PCF) announced 19 new Young Investigator (YI) Awards at the 22nd Annual Scientific Retreat in Washington, DC, held October 8-10, 2015. Awardees were selected from a pool of 107 applicants from 65 institutions in 9 countries. To date, PCF... Read More

08/04/2015

6 New Movember Foundation – PCF Challenge Awards Advance Precision Medicine and Novel Treatments for Lethal Prostate Cancer

Nearly $7 Million to Fund Lifesaving Research SANTA MONICA, CA August 4, 2015 -- The Prostate Cancer Foundation (PCF) announces that it has received nearly $7 million from the Movember Foundation, a valued partner since 2007. These funds were made possible by the 2014 Movember U.S. Campaign and will support... Read More

06/19/2015

EARLIER CHEMOTHERAPY MAY EXTEND PATIENT SURVIVAL IN MULTIPLE PROSTATE CANCER SETTINGS

June 19, 2015 -- Chemotherapy has traditionally been used to treat prostate cancer patients only after they have developed resistance to hormone therapy. However, two new studies presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting found that the addition of taxane chemotherapy extended survival in several... Read More

06/16/2015

Prostate Cancer Foundation Steps Into The Ring To Knock Out Prostate Cancer For Good

Taps boxing legend Evander Holyfield and communications firm (add)ventures to produce public service announcement aimed at African-American men PR Newswire, SANTA MONICA, CA (June 16, 2015) -- The Prostate Cancer Foundation is throwing a one-two punch to knock out prostate cancer for good with the recent production of a public... Read More

06/02/2015

THE DISCOVERY OF NEW MOLECULAR MECHANISMS THAT MAY LINK OBESITY AND HIGH RISK PROSTATE CANCER

What this means for patients: Obesity is a known risk factor for prostate cancer, but the reasons for this remain unknown. This study identifies expression of chromatin remodeling genes as a likely mechanism linking these processes, and may lead to the development of therapies for obesity-related prostate cancer. June 2,... Read More